GSDMC and neoplasm: A recent study demonstrated that, under hypoxia, nuclear PD-L1 was found to enhance the expression of GSDMC, and breast cancer patients with an increased expression of GSDMC had poorer outcomes, suggesting that the chronic tumor necrosis induced by GSDMC in the center of hypoxia regions may promote tumor progression [77].